CHA News Article

Secretary Burwell Issues Declaration Supporting Development of Ebola Vaccines

Health and Human Services (HHS) Secretary Sylvia M. Burwell has announced a declaration under the Public Readiness and Emergency Preparedness (PREP) Act to facilitate the development and availability of experimental Ebola vaccines. The declaration provides immunity under U.S. law against legal claims related to the manufacturing, testing, development, distribution and administration of three vaccines for Ebola virus disease. It does not, generally, provide immunity for a claim brought in a court outside the U.S.

According to HHS, the PREP Act was designed to facilitate the development of medical countermeasures to respond to urgent public health needs, including the development of critical vaccines such as those to prevent the spread of Ebola.

The PREP Act declaration is expected to strengthen the incentive to conduct research and spur development, manufacturing, and the potential use of three vaccines in large scale vaccination campaigns in West Africa. The three vaccine candidates provided legal protection are produced by GlaxoSmithKline, BioProtection Services Corporation and Janssen Corporation.

For more information about Secretary Burwell’s declaration, see the complete HHS press release. For more information about the PREP Act, visit